India's Sun Pharma to buy Organon in $11.75 billion all-cash deal - Reuters

Chronological Source Flow
Back

AI Fusion Summary

Sun Pharma, an Indian drugmaker, will acquire US-listed Organon for approximately $11.8 billion, a deal that expands its presence in the U.S. market and enhances its portfolio of pharmaceuticals.
#SUN_PHARMA #ORGANON #ACQUISITION #US #INDIA #PHARMA #MERGER #PHARMA_DEAL
27/04 03:01 google.com
3 Πηγές

India's Sun Pharma to buy Organon in $11.75 billion all-cash deal - Reuters

POLITICS
27/04 03:19 bloomberg.com

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

NSE:SUNPNYS:OGN
27/04 03:20 investing.com

India’s Sun Pharma to acquire US-listed Organon in $11.8 billion deal

POLITICS
Comments
Loading...
0